Congestive Heart Failure - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Randomized Placebo-Controlled Trial
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL
Association of Cardiovascular Disease With Respiratory Disease
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome?
Determinants of exercise intolerance in heart failure with preserved ejection fraction: A systematic review and meta-analysis
Respiratory Syncytial Virus and Associations With Cardiovascular Disease in Adults
Design of a bilevel clinical trial targeting adherence in heart failure patients and their providers: The Congestive Heart Failure Adherence Redesign Trial (CHART)
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial
Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol

Clinical Trial

December 8, 2020 Vol 142, Issue 23

JOURNAL：Circulation.

Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial

F Cosentino , CP Cannon , DZI Cherney et al.

3069

Keywords: ertugliflozin;T2DM; ASCVD, HF

Full Text PDF